abstract |
The present invention features methods for screening modulators of methyltransferase activity, in particular modulators of retinoblastoma methylation by SMYD3, and determining methyltransferase activity of polypeptides. The present invention further provides methods or pharmaceutical compositions for the prevention or treatment of colorectal cancer, liver cancer, bladder cancer and / or breast cancer using the modulators thus identified. |